News

Bank of America Announces QuarterlyDividend for 2026

Bank of America Announces QuarterlyDividend for 2026

Bank of America Declares Significant Cash Dividends

Bank of America Corporation recently announced exciting news that is sure to benefit its shareholders. The Board of Directors has declared a quarterly cash dividend on Bank of America common stock set at $0.28 per share. This dividend is scheduled to be paid on March 27, 2026, to those shareholders who are listed on the records by March 6, 2026.

Preferred Stock Dividend Announcement

In addition to the common stock dividend, the Board also declared a regular cash dividend of $1.75 per share on its 7% Cumulative Redeemable Preferred Stock, Series B. This series will see its dividend payable on April 24, 2026, for shareholders recorded as of April 10, 2026.

Overview of Bank of America

Bank of America stands as one of the foremost financial institutions globally, catering to a variety of clients that includes individual customers, small businesses, middle-market enterprises, and large corporations. They offer a comprehensive range of banking, investment, asset management, and risk management services. The convenience offered to clients is remarkable, with nearly 70 million customers utilizing about 3,600 retail financial centers and approximately 15,000 ATMs across the nation. Additionally, their digital banking services are award-winning, boasting roughly 59 million verified digital users.

The Global Reach of Bank of America

The company prides itself on being a global powerhouse in wealth management, corporate and investment banking, and trading across a diverse array of asset classes. Serving corporations, governments, institutions, and individuals worldwide underscores Bank of America’s reach. They support around 4 million small business households, delivering innovative and user-friendly online products and services that enhance their clients' experience.

Connecting with Stakeholders

Bank of America Corporation stock is traded on the New York Stock Exchange under the ticker symbol NYSE: BAC. Their operations extend across the United States, its territories, and in over 35 countries, illustrating their large international footprint.

Contacting Investor Relations

For investor inquiries, individuals can contact Lee McEntire at Bank of America via phone at 1.980.388.6780. Alternatively, for fixed income queries, Jonathan G. Blum is also available at 1.212.449.3112.

Media Relations at Bank of America

Reporters seeking information can reach out to Jocelyn Seidenfeld, who is available at 1.646.743.3356. This proactive approach to communications reflects the company’s commitment to transparency and engagement with various stakeholders.

Frequently Asked Questions

What is the amount of the common stock dividend announced?

The common stock dividend is declared at $0.28 per share.

When will the dividends be paid out?

The common stock dividend payout is scheduled for March 27, 2026.

What is the ticker symbol for Bank of America?

The stock is traded under the ticker symbol NYSE: BAC on the New York Stock Exchange.

How many retail financial centers does Bank of America have?

Bank of America operates around 3,600 retail financial centers nationwide.

What services does Bank of America provide?

Bank of America offers a full range of banking, investing, asset management, and financial risk management services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading